Clinical Trials Logo

Pelvic Inflammatory Disease clinical trials

View clinical trials related to Pelvic Inflammatory Disease.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05460546 Completed - Chronic Pelvic Pain Clinical Trials

The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

Start date: January 19, 2021
Phase: Phase 2
Study type: Interventional

This phase II trial attempts to evaluate the efficacy and safety of Jincaopian Tablets in the treatment of subjects with chronic pelvic pain after pelvic inflammatory disease.

NCT ID: NCT04723069 Completed - Clinical trials for Pelvic Inflammatory Disease

Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases

Start date: September 21, 2021
Phase: Phase 2
Study type: Interventional

Randomized, double blind and positive-controlled clinical trial to assess the efficacy and safety of Fuke Qianjin Capsule compared to Doxycycline Hyclate Tablet in patients with mild to medium PID and its sequalae.

NCT ID: NCT04179149 Completed - Quality of Life Clinical Trials

Enriched Environments in Endometriosis

Start date: September 13, 2019
Phase: N/A
Study type: Interventional

The investigators propose to conduct a randomized behavioral trial that will produce a clinically useful multi-level integrative medicine model to be used in stress- and inflammation-related disorders that can easily be implemented with current pharmacological interventions to alleviate pain and improve QoL.

NCT ID: NCT04104542 Completed - Depression Clinical Trials

MOCHI: An RCT of Mindfulness as Treatment for Chronic Pelvic Pain in AD Women

AD
Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Subject Population: Active duty (AD) women with chronic pelvic pain (CPP) have different demands and stressors placed on them compared with their civilian counterparts. Due to a decrease in functionality from pain, not addressing these women's untreated CPP could be detrimental in readiness missions. With limited studies on AD women with CPP or sufficient treatments available, this study seeks to compare the effects on pain, depression, and inflammation in the mindfulness-based stress reduction (MBSR) group with a self-paced Healthy Lifestyle (HL) education control. Research Design: This randomized controlled trial will compare depression, pain, and biomarkers known for inflammation and pain in AD women with CPP pre-post an 8-week MBSR online intervention (n=55) with a self-directed Healthy Lifestyle control (n=55). Instruments: All participants will complete a demographic worksheet, Five Facets of Mindfulness Questionnaire (FFQ), a brief pain inventory (BPI), and a Patient Health Questionnaire (PHQ-9) pre-post intervention (MBSR or HL). Procedure: Participants will have 8-weeks of online training with voice-over slides in RedCap. The primary investigator will contact participants weekly for both groups and review diaries to help monitor fidelity and guide progress. Blood will be drawn for biomarkers for inflammation and pain and questionnaires will be completed pre-post intervention.

NCT ID: NCT03797911 Completed - Chronic Pain Clinical Trials

Efficacy of Resistive Capacitive Monopolar Radiofrequency in the Physiotherapeutic Treatment of Chronic Pelvic Pain: RCT

Start date: March 23, 2019
Phase: N/A
Study type: Interventional

This study evaluates if the application of resistive capacitive monopolar radiofrequency therapy associated with physiotherapeutic techniques and pain education provides benefits with respect to physiotherapy and pain education techniques alone in the management of patients with chronic pelvic pain.

NCT ID: NCT03054402 Completed - Clinical trials for Pelvic Inflammatory Disease

First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845

Start date: February 13, 2017
Phase: Phase 1
Study type: Interventional

This study is a first in human study that will investigate the safety, tolerability and pharmacokinetics and explore the pharmacodynamics of ascending single doses of BAY1834845 using a placebo controlled, randomized, single center design.

NCT ID: NCT01842100 Completed - Clinical trials for Sexually Transmitted Infections

To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy

Start date: September 1999
Phase: N/A
Study type: Interventional

Screen-and-treat approach reduces postabortal pelvic inflammatory disease after induced abortion, and at the same time alters women's sexual behavior and prevents further re-infection by sexually transmitted infections when compared to the universal antibiotic prophylaxis strategy.

NCT ID: NCT01799356 Completed - Clinical trials for Pelvic Inflammatory Disease

Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials

Start date: June 2010
Phase: Phase 4
Study type: Interventional

We aimed to compare efficacy and safety of combination therapy with oral ofloxacin, 400 mg twice daily, plus oral metronidazole, 500 mg twice daily, for 14 days, with moxifloxacin monotherapy, 400 mg once daily, for 14 days

NCT ID: NCT01793584 Completed - Endometriosis Clinical Trials

Surgical Success After Laparoscopic vs Abdominal Hysterectomy

Start date: February 2013
Phase: N/A
Study type: Interventional

The purpose of the proposed pilot study is to investigate the effectiveness, cost, safety, and long-term impact on quality of life of laparoscopic hysterectomy (LH) in relation to abdominal hysterectomy (AH) for the treatment of benign gynecologic disease in women through a randomized surgical trial.

NCT ID: NCT01671280 Completed - Clinical trials for Community-acquired Pneumonia

Drug Use Investigation Of Azithromycin IV For Community-Acquired Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)

RESCUE
Start date: September 2012
Phase: N/A
Study type: Observational

To collect the efficacy and safety information of Azithromycin IV related to their appropriate use in daily practice